BIBLIOGRAFIE

1. ASH: Clinical Practice guideline on the evaluation and management of von

Willebrand disease,NIH Pub,2012
2. Befus D, Denburg J. Basophilic Leukocytes: Mast Cells and Basophils. In Wintrobe’s
Clinical Hematology. Lippincott, Williams, and Wilkins, Philadelphia, 11 ed. ed.
2004, 336-345.
3. Bombeli T, Spahn DR. Updates in perioperative coagulation. BJA 2004; 93:275-87.
4. Carmel L. Megaloblastic Anemias: Disorders of Impaired DNA Synthesis. In
Wintrobe’s Clinical Hematology. Lippincott, Williams, and Wilkins, Philadelphia, 11
ed. 2004, 1367-1413.
5. Chiorean M, Copotoiu S, Ghiţescu I. Anestezia în raport cu afecţiunile coexistente. În
Acalovschi I: Anestezie clinică, Ed.Clusium, Cluj-Napoca, 2001, p.345-87.
6. Collins PW, Bjorkman S, Fischer K, Blanchette V, Schroth P et al. Factor VIII
requirement to maintain a target plasma level in the prophylactic treatment of severe
hemophilia A: Influences ofvariance in pharmacokinetics and treatment regimes. J
Thromb Haemost 2010; 8(2):269-75
7. DeMott W, Tilzer L. Hematology. In Laboratory Test Handbook. Hudson (Cleveland)
ed. 1994, 517-617.
8. Desai S. Complete Blood Count. In Clinicians’s Guide to Laboratory Medicine.
Hudson (Cleveland) ed. 2004, 13-18.
9. Filipescu D, Luchian M, Ghenu O, et al. Factorul VII activat recombinat. Date
farmacologice. RRATI 2004;11:11-20.
10. Fischbach F. Blood Studies: Hematology and Coagulation; Appendix J: Effects of the
Most Commonly Used Drugs on Frequently Ordered Laboratory Tests. In A Manual
of Laboratory and Diagnostic Tests. Lippincott Williams & Wilkins, Philadelphia, 8
ed. 2009, 67-110, 1227-1247.
11. Franchini M, Mannucci PM. Hemophilia A in the third millennium. Blood Rev 2013;
27: 179-8425
12. Franchini M, Rossetti G, Tagliaferri A, Pattacini C, Pozzoli D, Lorenz C et al. Dental
procedures in adult patients with hereditary bleeding disorders: 10 years exp erience
in three Italian Hemophilia Centers. Haemophilia 2005; 11(5): 504
13. Ghidul European de management al hemofiliei “Guidelines for the management of
hemophilia”, Srivastava A et al, Haemophilia 2012
14. Ghidul WFH de management al hemofiliei, Editia a 2-a, Blackwell Publishing Ltd.,
2012
15. Giangrande Paul:Pregnancy in women with inherited bleeding disorders, WFH,2003
16. Giangrande PLF. Inhibitory antibodies. Blood Coagulation &Fibrinolysis 1996;7:134-
8.
17. Glader B. Anemia: General Considerations. In Wintrobe’s Clinical Hematology,
Philadelphia. 2004, 948-975.
18. Hurford WE, Bailin MT, Davison JK, et al. Clinical anesthesia procedures of the
Massachusetts General Hospital, Lippincott Williams, 5th ed, 1998.
19. Iurian Ioan Sorin Dr. - Boli hemato-oncologice, Protocoale de diagnostic si tratament
in pediatrie, pg. 189-195
20. Kelly RE, Yao FSF. Hemophilia and coagulation dsorders. În Yao FSF:
Anesthesiology Problem-oriented patient management, Lippincott Raven, 1998,
p.763-74.
21. Laborator Synevo. Referintele specifice tehnologiei de lucru utilizate. 2010. Ref
Type: Catalog
22. Lacy P, Becker A, Moqbel R. The Human Eosinophil. In Wintrobe’s Clinical
Hematology. Philadelphia, ed. 2004, 311-329.
23. Laffan M-The diagnosis and management of von Wille brand disease: a United
Kingdom Haemophilia Center Doctors Organisation guideline approved by the British
Committee for Standards in Hematology,BJH,2014,167,453-465.
24. Levine S. Miscellaneous Causes of Thrombocytopenia. In Wintrobe’s Clinical
Hematology, Philadelphia. Philadelphia ed. 2004, 1565-1570.
25. Levine S. Thrombocytopenia: Pathophysiology and Classification. In Wintrobe’s
Clinical Hematology. Philadelphia ed. 2004, 1529-1531.
26. Levine S. Thrombocytosis. In Wintrobe’s Clinical Hematology. Philadelphia ed.
2004, 1591-1597.
27. Mannuccio Mannucci P : Desmopressin in the treatment of bleeding disorders:the first
tw enty years,WFH,1998
28. Mannucio Mannucci P: Evidence –based recommendations on the treatment of von
Willebrand disease in Italy, Blood Transfus.2009,7,2450
29. Means R. Erythrocytosis. In Wintrobe’s Clinical Hematology. Philadelphia ed. 2004,
1495-1505.
30. Menzebach A, Cassens U, Van Aken H. Strategies to reduce perioperative blood loss
related to non-surgical bleeding. EJA2003; 20:764-70.
31. Mogoşeanu A. Problemele tulburărilor de hemostază. JSRATI 1997; 2:111-23.
32. Pabinger I, Heistinger M, Muntean W, S-E Reitter-Pfoertner, Rosenlechner S, Schindl
T, Schuster G, Streif W, Thom K, Male C. Hamophiliebehandlung in Osterreich.
Wien Wochenschr 2015; 127(3): S115-S130
33. Paraskevas F. Lymphocytes and Lymphatic Organs. In Wintrobe’s Clinical
Hematology. Philadelphia, ed. 2004, 409-433.
34. Perkins S. Examination of the Blood and Bone Marrow. In Wintrobe’s Clinical
Hematology. Philadelphia, ed. 2004, 3-21.
35. Physiotherapy –management of haemophilia. Buzzard B, Beeton K. WFH, Blackwell
-Science, 2010
36. DELIA MUT POPESCU- note de curs, hematologie clinică, ed. medicală, pg.303-312
37. Popescu D. Hematologie clinică, Ed Medicală, Bucureşti, 1994.
38. Principiile Europene de management a l hemofiliei “European Principles of
haemophilia care”, Colvin, Haemophilia 2008
39. Protocols for the treatment of ha4emophili a and von Willebrand disease,Haemophilia
if Georgia,USA,WFH,2008
40. Rapaport SI. Preoperative hemostatic evaluation. Which test, if any? Blood 1993;
61:229-31.
41. Recomandă rile EDQM de tratament a l hemofiliei cu factori de coagulare „Kreuth
III: European consensus p roposal for treatment of haemophilia with coagulation
factor concentrates” Giangrande, Haemophilia 2014
42. Rocino A, Coppola A, Franchini M, Castaman G, Sant oro C, Zanon E, Santagostino
E, Morfini M. Principles of treatment and update of recommendations for the
management of haemophilia and congenital bleeding disorders in Italy. Blood
Transfus 2014; 12: 575-98
43. Rodgers G. Diagnostic Approach of the Bleeding Disorders. In Wintrobe’s Clinical
Hematology. Philadelphia ed. 2004, 1511-1526.
44. Rusen L. Terapia cu NovoSeven a hemofiliei cu inhibitori. RRATI 2004; 11:33-9.
45. Samama M. Assessment of the coagulation in the perioperative setting. Refresher
Course Lectures, ESA 2000, p.79-85.
46. Skubitz K. Neutrofilic Leukocytes. In Wintrobe’s Clinical Hematology. Philadelphia
ed. 2004, 268-303.
47. Stoelting RK, Dierdof SF, McCammon RL. Anesthesia and co- existing diseases, 3rd
ed, Churhill Livingstone, 1993.
48. Thomas L, Bartl R. Hematology. In Clinical Laboratory Diagnostics. 1998, 463-547.
49. Watts R. Neutropenia. In Wintrobe’s Clinical Hematology. Philadelphia ed. 2004,
1777-1795.
50. J Wallach. Hematologic Diseases. In Interpretation of Diagnostic Tests. Philadelphia
ed. 1996, 293-316.
51. B Weinberg. Monunuclear Phagocytes. In Wintrobe’s Clinical Hematology.
Philadelphia ed. 2004, 349-377.
52. Wissenschaftlicher Beirat der Osterreichischen Hamophiliegesellschaft.Konsensus
uber die Verwendung von Faktorenkonzentraten bei Patienten mit Hamophilie
(versionv.9.11.2012)
http://bluter.at/joomia/new_site/images/stories/Konsensus_9_November2012.pdf.
Zugegriffen:10Jan.2013
53. World Federation of Hemophilia Guidelines for the Management of Hemophilia:
Optimal use of prophylaxis and Management during acute Bleeding episodes episodes
and invasive procedures